Bharat Biotech's Covid-19 nasal vaccine phase III trials completed


Content Team
Image Credit: zee news

Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday said that the clinical phase III trials of the Covid-19 nasal vaccine have been completed and the company will submit its data with DCGI next month. In an exclusive interview with ANI, Dr Ella said, "We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency.